New York State Common Retirement Fund
MRNA icon

New York State Common Retirement Fund’s Moderna MRNA Stock Holding History

New York State Common Retirement Fund’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8M Buy
211,300
+34,500
+20% +$1.78M 0.02% 597
2026
Q1 		$8.98M Hold
176,800
– – 0.01% 776
2025
Q4 		$5.21M Hold
176,800
– – 0.01% 1021
2025
Q3 		$4.57M Sell
176,800
-5,800
-3% -$162K 0.01% 1105
2025
Q2 		$5.04M Sell
182,600
-182,167
-50% -$4.8M 0.01% 1066
2025
Q1 		$10.3M Sell
364,767
-33,365
-8% -$1.18M 0.02% 699
2024
Q4 		$16.6M Sell
398,132
-2,600
-0.6% -$124K 0.02% 544
2024
Q3 		$26.8M Sell
400,732
-20,030
-5% -$1.84M 0.04% 368
2024
Q2 		$50M Sell
420,762
-13,085
-3% -$1.66M 0.07% 224
2024
Q1 		$46.2M Sell
433,847
-21,560
-5% -$2.17M 0.06% 255
2023
Q4 		$45.3M Sell
455,407
-37,691
-8% -$3.17M 0.06% 265
2023
Q3 		$50.9M Sell
493,098
-42,354
-8% -$4.72M 0.07% 228
2023
Q2 		$65.1M Sell
535,452
-7,354
-1% -$981K 0.08% 208
2023
Q1 		$83.4M Sell
542,806
-39,884
-7% -$6.58M 0.11% 163
2022
Q4 		$105M Sell
582,690
-3,534
-0.6% -$578K 0.14% 135
2022
Q3 		$69.3M Sell
586,224
-40,871
-7% -$6.2M 0.1% 184
2022
Q2 		$89.6M Buy
627,095
+607
+0.1% +$86.8K 0.12% 166
2022
Q1 		$108M Sell
626,488
-13,048
-2% -$2.2M 0.12% 159
2021
Q4 		$162M Sell
639,536
-5,244
-0.8% -$1.53M 0.16% 116
2021
Q3 		$248M Sell
644,780
-21,116
-3% -$7.79M 0.26% 69
2021
Q2 		$156M Buy
665,896
+305,020
+85% +$54.5M 0.16% 125
2021
Q1 		$47.3M Sell
360,876
-28,400
-7% -$4.12M 0.05% 331
2020
Q4 		$40.7M Sell
389,276
-30,148
-7% -$3.05M 0.05% 385
2020
Q3 		$29.7M Sell
419,424
-15,100
-3% -$1.05M 0.04% 441
2020
Q2 		$27.9M Buy
434,524
+72,115
+20% +$3.95M 0.04% 466
2020
Q1 		$10.9M Buy
362,409
+400
+0.1% +$9.2K 0.02% 755
2019
Q4 		$7.08M Buy
362,009
+206,100
+132% +$3.66M 0.01% 1100
2019
Q3 		$2.48M Buy
155,909
+119,309
+326% +$1.76M ﹤0.01% 1529
2019
Q2 		$536K Buy
36,600
+6,000
+20% +$129K ﹤0.01% 2350
2019
Q1 		$623K Buy
+30,600
New +$568K ﹤0.01% 2201

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

New York State Common Retirement Fund's MRNA Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Moderna (MRNA) stake by 20% in Q2 2026, buying an estimated $1.78M and bringing the position to 211,300 shares worth $14.8M. The position accounts for 0.02% of the portfolio, ranked #597.

New York State Common Retirement Fund first reported a position in MRNA in Q1 2019 and has held it in 30 quarters since. The position peaked at $248M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • New York State Common Retirement Fund held 211,300 shares of Moderna worth $14.8M as of Q2 2026.
  • New York State Common Retirement Fund bought 34,500 Moderna shares in Q2 2026, an estimated $1.78M.
  • Moderna made up 0.02% of New York State Common Retirement Fund's portfolio in Q2 2026, its #597 holding.
  • New York State Common Retirement Fund first reported a position in Moderna in Q1 2019 and has held it in 30 quarters since.
  • New York State Common Retirement Fund's Moderna position peaked at $248M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.